Press Releases

Press Releases - Current

Press Releases - 2015

Press Releases - 2014

  December 26, 2013
CEL-SCI Corporation Announces Closing of Public Offering and Exercise of Over-Allotment Option for Aggregate Gross Proceeds of $3.3 Million
  December 19, 2013
CEL-SCI Corporation Prices $3.0 Million Public Offering of Common Stock and Warrants
  December 18, 2013
CEL-SCI Corporation Announces Proposed Public Offering of Common Stock and Warrants
  December 12, 2013
CEL-SCI Corporation Releases Letter to Shareholders
  December 9, 2013
CEL-SCI Warrants Approved for Trading Under the Ticker Symbol "CSCIW"
  December 5, 2013
CEL-SCI Receives Government Approval in Bosnia and Herzegovina to Commence Phase III Clinical Trial of Multikine in Head and Neck Cancer
  November 20, 2013
CEL-SCI Conducts Meeting of North American Clinical Centers to Support Success of Its Phase III Cancer Trial with Multikine
  November 12, 2013
CEL-SCI Receives Croatian Government Approval to Commence Phase III Clinical Trial of Multikine in Head and Neck Cancer
  November 5, 2013
CEL-SCI Corporation Announces IDMC Conclusions from Interim Review of Phase III Head and Neck Cancer Trial Data
  October 31, 2013
CEL-SCI Announces Initiation of Arbitration against Former Clinical Research Organization
  October 29, 2013
CEL-SCI and Ergomed Sign Co-Development and Profit Sharing Agreement for Multikine in HIV/HPV Co-Infected Men and Women with Peri-Anal Warts
  October 21, 2013
CEL-SCI Corporation Holds Clinical Investigator Meeting for 56 European Centers Participating in Ongoing Phase III Cancer Trial with Multikine
  October 18, 2013
CEL-SCI Regains Listing Compliance with NYSE MKT
  October 15, 2013
CEL-SCI and Ergomed Sign Co-Development and Profit Sharing Agreement for Multikine in HIV/HPV Co-Infected Women with Cervical Dysplasia
  October 11, 2013
CEL-SCI Corporation Announces Closing of Public Stock Offering
  October 8, 2013
CEL-SCI Corporation Prices $17.8 Million Public Offering of Common Stock and Warrants
  October 7, 2013
CEL-SCI Corporation Announces Proposed Public Offering of Common Stock and Warrants
  October 7, 2013
CEL-SCI Announces Cooperative Research and Development Agreement (CRADA) for Multikine with US Navy
  October 4, 2013
CEL-SCI Announces That NYSE MKT Granted an Extension to Regain Compliance
  September 20, 2013
CEL-SCI Corporation Announces 1-For-10 Reverse Stock Split
  September 9, 2013
CEL-SCI Corporation's Manufacturing and Laboratory Operations Deemed Compliant with GMP Requirements Following Audit by European Union Qualified Person for a Second Time
  September 3, 2013
>CEL-SCI Announces That NYSE MKT Approves Plan
  August 9, 2013
CEL-SCI Corporation Reports Third Quarter 2013 Financial Results
  July 25, 2013
CEL-SCI and NIAID Publish Data Showing that CEL-SCI's LEAPS Technology Halted Progression of Lethal Influenza in Three Different Influenza Virus Strains, Including a Drug-Resistant and a 2009 Pandemic Flu Strain
  July 19, 2013
CEL-SCI Reports on NYSE MKT Noncompliance Notice and Compliance Plan
  JUNE 26, 2013
CEL-SCI Corporation Announces Results of Annual Shareholders' Meeting and Adjournment of Meeting to July 25, 2013 With Respect to Proposal Concerning Stock Option Plan
  MAY 10, 2013
CEL-SCI Corporation Reports Second Quarter 2013 Financial Results
  MAY 6, 2013
CEL-SCI Presents Data Showing LEAPS Vaccine is Successful in Reducing Rheumatoid Arthritis Index Score in a Second Animal Model
  MAY 3, 2013
CEL-SCI to Present at the American Association of Immunologists 100th Annual Meeting on Saturday May 4th
  APRIL 23, 2013
CEL-SCI Corporation Provides Update on Phase III Clinical Trial
  APRIL 8, 2013
CEL-SCI Corporation Announces That NIAID Collaborators Have Submitted Bird Flu Study for Publication to Prestigious Scientific Journal
  FEBRUARY 25, 2013
CEL-SCI Announces Initiation of New Sites for Multikine Phase III Clinical Study for Head and Neck Cancer in Taiwan
  FEBRUARY 8, 2013
CEL-SCI Corporation Reports First Quarter 2013 Financial Results
  FEBRUARY 7, 2013
CEL-SCI to Present at 15TH Annual BIO CEO & Investor Conference
  JANUARY 31, 2013
CEL-SCI and Northeast Ohio Medical University Develop Novel Cancer Vaccine That Prevents and Treats Breast Cancer

Press Releases - 2012

Press Releases - 2011